Circulating levels of soluble Dipeptidylpeptidase-4 are reduced in human subjects hospitalized for severe COVID-19 infections-Reference-Cited by-同舟云学术

Circulating levels of soluble Dipeptidylpeptidase-4 are reduced in human subjects hospitalized for severe COVID-19 infections

Published:2020-09-21 Issue:11 Volume:44 Page:2335-2338
ISSN:0307-0565
Container-title:International Journal of Obesity
language:en
Short-container-title:Int J Obes

Author:

Schlicht Kristina,Rohmann Nathalie,Geisler Corinna^ORCID,Hollstein Tim,Knappe Carina,Hartmann Katharina,Schwarz Jeanette,Tran Florian,Schunk Domagoj^ORCID,Junker Ralf,Bahmer Thomas,Rosenstiel Philip,Schulte Dominik,Türk Kathrin,Franke Andre^ORCID,Schreiber Stefan,Laudes Matthias^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Link

https://www.nature.com/articles/s41366-020-00689-y.pdf

Reference16 articles.

1. Velavan T, Meyer C. The COVID-19 epidemic. Trop Med Int Health. 2020;3:278–80.

2. Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical & mortal COVID-19 cases. J Infection. 2020;81:e16–25.

3. Miyara M, Tubach F, Pourcher V, Morelot-Panzini C, Pernet J, Haroche J, et al. Low incidence of daily active tobacco smoking in patients with symptomatic COVID-19. Qeios ID: WPP19W.3. 2020.

4. Wu Q, Zhou L, Sun X, Yan Z, Hu C, Wu J, et al. Altered lipid metabolism in recovered SARS patients twelve years after infection. Sci Rep. 2017;1:9110.

5. Raj V, Mou H, Smits S, Dekkers D, Müller M, Dijkman R, et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013;7440:251–4.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin and Metformin Administration: Unravelling the Multifaceted Association with Mortality across Various Clinical Settings Considering Type 2 Diabetes Mellitus and COVID-19;Biomedicines;2024-03-07

2. Diabetic individuals with COVID-19 exhibit reduced efficacy of gliptins in inhibiting dipeptidyl peptidase 4 (DPP4). A suggested explanation for increased COVID-19 susceptibility in patients with type 2 diabetes mellitus (T2DM);Life Sciences;2024-01

3. VEGFR and DPP-IV as Markers of Severe COVID-19 and Predictors of ICU Admission;International Journal of Molecular Sciences;2023-11-30

4. Changes in Adenosine Deaminase Activity and Endothelial Dysfunction after Mild Coronavirus Disease-2019;International Journal of Molecular Sciences;2023-08-24

5. ACE2, ACE, DPPIV, PREP and CAT L enzymatic activities in COVID-19: imbalance of ACE2/ACE ratio and potential RAAS dysregulation in severe cases;Inflammation Research;2023-08